Lucid Diagnostics (LUCD) EBT Growth (1y) (2021 - 2026)
Powered by 
Analysis
Lucid Diagnostics (LUCD) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.02 Bn | 45.92 Bn | 486.15 Mn | 33.21% |
| 2 | Labcorp Holdings | 26.25 Bn | 26.11 Bn | 1.11 Bn | 26.81% |
| 3 | Quest Diagnostics | 25.95 Bn | 25.32 Bn | 1.03 Bn | 7.29% |
| 4 | Guardant Health | 21.84 Bn | 20.79 Bn | 219.03 Mn | -20.12% |
| 5 | Tempus AI | 11.19 Bn | 10.38 Bn | 274.25 Mn | 121.75% |
| 6 | Caris Life Sciences | 6.94 Bn | 6.14 Bn | 182.38 Mn | 99.14% |
| 7 | Sotera Health | 5.24 Bn | 4.89 Bn | 177.96 Mn | 313.03% |
| 8 | BillionToOne | 4.70 Bn | 4.15 Bn | 77.11 Mn | 3,340.52% |
| 9 | iRhythm Holdings | 4.00 Bn | 3.41 Bn | 163.21 Mn | 97.35% |
| 10 | Lucid Diagnostics | 155.38 Mn | 121.98 Mn | 55,000.00 | -163.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -163.28% |
| Mar 31, 2026 | 48.31% |
| Dec 31, 2025 | -40.94% |
| Sep 30, 2025 | 15.96% |
| Jun 30, 2025 | 59.66% |
| Mar 31, 2025 | -153.56% |
| Dec 31, 2024 | -6.57% |
| Sep 30, 2024 | 12.93% |
| Jun 30, 2024 | 3.30% |
| Mar 31, 2024 | 34.68% |
| Dec 31, 2023 | 27.45% |
| Sep 30, 2023 | 0.98% |
| Jun 30, 2023 | 22.18% |
| Mar 31, 2023 | -32.41% |
| Dec 31, 2022 | -32.04% |
| Sep 30, 2022 | -106.25% |
| Jun 30, 2022 | -137.29% |
| Mar 31, 2022 | -235.89% |
| Dec 31, 2021 | -313.97% |
| Sep 30, 2021 | -244.12% |